Skip to content

Author

Junfang Wu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

SGLT2 inhibitor ameliorates hypertension by regulating the CYP4A/20-HETE pathway in the kidney

Abstract Sodium–glucose transport protein 2 inhibitors (SGLT2i), initially developed as antidiabetic agents and now established as foundational therapies for heart failure, have also shown antihypertensive effects in clinical trials involving patients with diabetes and heart failure. However, the underlying mechanisms...

Zhi-Tong Zhou, Wei-Jian Hang, Rui Zhao et al. · 0 citations
Open access Aug 2026

Myocilin drives cardiomyocyte mitochondrial dysfunction via SLC3A2-dependent redox imbalance in heart failure

Fibroblast-derived myocilin is identified as a fibroblast-derived mediator that drives cardiomyocyte mitochondrial dysfunction and ROS production in HF and a fibroblast–cardiomyocyte signaling axis in which myocilin disrupts cardiomyocyte metabolic homeostasis is identified.

Xiaoyue Yu, Junxia Zhang, Jun-Fang Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.